Name: China's pharma rise: why global drugmakers are buying in
Uploaded: 2026-08-12T14:02:39+08:00
Duration: 1 min 38 s
Description: China is becoming a major force in global drug innovation. In the first half of 2026, Chinese companies secured eight of the world's ten largest pharmaceutical out-licensing deals, worth a record $110 billion. It is happening despite growing US scrutiny

Language

RSS

Newsletters

Home

China

World

Politics

Business

Sci-Tech

Health

Opinions

Video

Live

Radio

World Asia-Pacific Middle East Europe Americas Africa

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

China is becoming a major force in global drug innovation. In the first half of 2026, Chinese companies secured eight of the world's ten largest pharmaceutical out-licensing deals, worth a record $110 billion. It is happening despite growing US scrutiny over Chinese clinical data.

Why is global drugmakers betting big on China? And where do cutting-edge AI and traditional medicine fit into the global race to treat disease? CGTN's Huang Fei explains.

01:39

Open in CGTN APP for better experience

Search Trends